Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Use of Nucleic Acid Amplification Testing for Rapid Detection of Mycobacterium tuberculosis Complex Among US Tuberculosis Patients, 2011‒2017.

Autor: Kumar V; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Dalton TL; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Armstrong LR; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Whitesell A; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Li R; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Starks AM; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2021 Oct 20; Vol. 8 (11), pp. ofab528. Date of Electronic Publication: 2021 Oct 20 (Print Publication: 2021).

Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion.

Autor: Click ES; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Kurbatova EV; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Alexander H; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Dalton TL; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Chen MP; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Posey JE; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Ershova J; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Cegielski JP; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2020 Jun 11; Vol. 221 (12), pp. 2072-2082.

Validation of Novel Mycobacterium tuberculosis Isoniazid Resistance Mutations Not Detectable by Common Molecular Tests.

Autor: Kandler JL; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Mercante AD; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Dalton TL; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Ezewudo MN; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Critical Path Institute, Tucson, Arizona, USA., Cowan LS; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Burns SP; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Metchock B; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Cegielski P; Division of Global HIV & TB, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Posey JE; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA hzp9@cdc.gov.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2018 Sep 24; Vol. 62 (10). Date of Electronic Publication: 2018 Sep 24 (Print Publication: 2018).

Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.

Autor: Campbell PJ; Mycobacteriology Laboratory Branch, Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Bldg. 17, Room 4029, M/S F08, Atlanta, GA 30333, USA., Morlock GP, Sikes RD, Dalton TL, Metchock B, Starks AM, Hooks DP, Cowan LS, Plikaytis BB, Posey JE

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2011 May; Vol. 55 (5), pp. 2032-41. Date of Electronic Publication: 2011 Feb 07.